RLMD
Relmada Therapeutics, Inc.Company with tickers: RLMD
CIK
1553643
CUSIP
75955J402
Shares Outstanding
104,890,223
13F Activity (30d)
98 filings
98 filers
Price
$7.14
Market Cap
$738.43M
P/E Ratio
-4.92
EPS (Diluted)
$-1.45
52W High
$8.00
52W Low
$0.49
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $19,461,754 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $8,087,845 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-19,461,754 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-19,051,956 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.22 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.22 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |